Monitoring antimalarial drug resistance in India via sentinel sites: Outcomes and risk factors for treatment failure, 2009-2010;Surveillance de la résistance aux antipaludiques en Inde par l'intermédiaire de sites sentinelles: Résultats et facteurs de risque de l'échec du traitement, 2009-2010

Bulletin of the World Health Organization

Volumn 90, Issue 12, 2012, Pages 895-904

  Mishra, Neelima ^a   Singh, Jai Prakash Narayan ^a   Srivastava, Bina ^a   Arora, Usha ^b   Shah, Naman K ^a   Ghosh, S K ^c   Bhatt, R M ^d   Sharma, S K ^a   Das, M K ^e   Kumar, Ashwani ^c   Anvikar, Anupkumar R ^a   Kaitholia, Kamlesh ^a   Gupta, Ruchi ^a   Sonal, G S ^b   Dhariwal, C ^b   Valecha, Neena ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^b GOVERNMENT OF INDIA   (India)

^c National Institute of Malaria Research   (India)

^d National Institute of Malaria Research Field Unit   (India)

^e National Institute of Malaria Research   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE;

ANTIMALARIAL AGENT; DRUG RESISTANCE; GENOTYPE; HEALTH MONITORING; HEALTH RISK; MONITORING SYSTEM; MUTATION; POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CODON; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG MONITORING; FEMALE; FEVER; GASTRITIS; GENE MUTATION; GENOTYPE; HUMAN; INDIA; INFANT; JAUNDICE; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; OUTCOME ASSESSMENT; PARASITE CLEARANCE; PARASITE ISOLATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE INFECTION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; REINFECTION; SCHOOL CHILD; SEASON; SENTINEL SURVEILLANCE; SINGLE DRUG DOSE; STOMATITIS; SURVIVAL RATE; TREATMENT FAILURE; VOMITING;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG RESISTANCE, MICROBIAL; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; MALARIA, FALCIPARUM; MALARIA, VIVAX; PYRIMETHAMINE; RISK FACTORS; SULFADOXINE; TREATMENT OUTCOME;

INDIA;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 84870424373     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.109124     Document Type: Article

References (22)

1. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455-467. doi:10.1056/NEJMoa0808859 PMID:19641202
2. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis 2004;39:1336-1345. doi:10.1086/424663 PMID:15494911
3. Global report on antimalarial drug efficacy and drug resistance: 2000-2010. Geneva: World Health Organization; 2010. Available from: http://www.who.int/entity/malaria/publications/atoz/9789241500470/en/index.html [accessed 11 October 2012].
4. Seghal P, Sharma M, Sharma S. Resistance to chloroquine in falciparum malaria in Assam state, India. J Commun Dis 1973;5:175-180.
5. Garg M, Gopinathan N, Bodhe P, Kshirsagar NA. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 1995;89:656-657. doi:10.1016/0035-9203(95)90432-8 PMID:8594687
6. Pattanayak S, Roy RG. Malaria in India and the modified plan of operations for its control. J Commun Dis 1980;12:1-13. PMID:7451930
7. Wijeyaratne PM, Chand PB, Valecha N, Shahi B, Adak T, Ansari MA et al. Therapeutic efficacy of antimalarial drugs along the eastern Indo-Nepal border: a cross-border collaborative study. Trans R Soc Trop Med Hyg 2005;99:423-429. doi:10.1016/j.trstmh.2004.09.011 PMID:15837354
8. Shah NK, Dhillon GP, Dash AP, Arora U, Meshnick SR, Valecha N. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect Dis 2011;11:57-64. doi:10.1016/S1473-3099(10)70214-0 PMID:21183147
9. Ahmed A, Bararia D, Vinayak S, Yameen M, Biswas S, Dev V et al. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob Agents Chemother 2004;48:879-889. doi:10.1128/AAC.48.3.879-889.2004 PMID:14982779
10. Revised National Drug Policy (2010) for treatment of malaria. J Indian Med Assoc 2010;108:844-845. PMID:21661462
11. National Vector Borne Disease Control Programme [Internet]. Malaria. Delhi: NVBDCP; 2010. Available from: http://nvbdcp.gov.in/malaria2.html [accessed 18 October 2012].
12. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009.
13. Recommended genotyping procedures (RGPs) to identify parasite populations. Geneva: World Health Organization; 2008. Available from: http://www.who.int/malaria/publications/atoz/rgptext_sti/en/index.html [accessed 18 October 2012].
14. Ahmed A, Lumb V, Das MK, Dev V, Wajihullah, Sharma YD. Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India. Antimicrob Agents Chemother 2006;50:3934-3938. doi:10.1128/AAC.00732-06 PMID:16982787
15. Dev V, Phookan S, Barman K. Therapeutic efficacies of antimalarial drugs in the treatment of uncomplicated, Plasmodium falciparum malaria in Assam, north-eastern India. Ann Trop Med Parasitol 2003;97:783-91. PMID:14754490
16. Sharma R, Sharma G, Dhillon G. Epidemiology and control of malaria in India. Delhi: National Malaria Control Programme; 1996.
17. Andriantsoanirina V, Durand R, Pradines B, Baret E, Bouchier C, Ratsimbasoa A et al. In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum. Malar J 2011;10:283. doi:10.1186/1475-2875-10-283 PMID:21951962
18. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2010.
19. White NJ. Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol 1992;34:1-10. doi:10.1111/j.1365-2125.1992.tb04100.x PMID:1633062
20. Valecha N, Joshi H, Eapen A, Ravinderan J, Kumar A, Prajapati SK et al. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. Trans R Soc Trop Med Hyg 2006;100:831-837. doi:10.1016/j.trstmh.2004.09.011 PMID:15837354
21. Lin JT, Bethell D, Tyner SD, Lon C, Shah NK, Saunders DL et al. Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment. PLoS One 2011;6:e18716. doi:10.1371/journal.pone.0018716 PMID:21533092
22. White NJ. The parasite clearance curve. Malar J 2011;10:278. doi:10.1186/1475-2875-10-278 PMID:21939506